A new study from researchers at Beth Israel Deaconess Medical Center (BIDMC) suggests that some of the adverse events reported in the COVID-19 vaccine trials are attributable to the placebo effect.

A cheaper method to produce nanosurfaces could improve the accessibility of a spectroscopy technique that is widely used in industry.

A theoretical framework has been published that assesses the impact of various vaccination strategies on the rate of emergence for new variants.

Researchers have identified a mechanism by which Zika virus can escape detection by host cells, offering a new target for therapeutics.

A research team has discovered that orally administrated colloidal bismuth subcitrate together with N-acetyl cysteine could be a broad-spectrum anti-coronavirus cocktail therapy.

University of Wisconsin–Madison researchers and their collaborators are making progress toward developing universal vaccines against some the planet’s most harmful pathogens, including the virus family responsible for the COVID-19 pandemic.

When we talk about antibodies against COVID-19, we tend to mean the so-called neutralizing antibodies. But non-neutralizing antibodies may also be important in providing protection.

Nanoparticles are being used to deliver immunosuppressants to prevent rejection in islet cell transplant patients.

Scientists have identified a set of cellular receptors for at least three related alphaviruses shared across mosquitoes, humans and animals that host these viruses.

A research group has discovered the mechanism by which the Rhesus macaque Macaca mulatta naturally develops a lasting immune response against schistosomiasis.